Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002549569 | SCV001129658 | likely benign | Developmental and epileptic encephalopathy, 14; Autosomal dominant nocturnal frontal lobe epilepsy 5 | 2020-11-18 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000981675 | SCV001155837 | likely benign | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | KCNT1: BS1 |
Ambry Genetics | RCV002550565 | SCV003695918 | likely benign | Inborn genetic diseases | 2022-08-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003962950 | SCV004786046 | likely benign | KCNT1-related disorder | 2023-04-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |